The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07, FiscalAI reports. , Q4 organic growth of 11%, more than in sales, adjusted EPS growth (~11.8% to $13.63), and 2026 guidance of and EPS of $14.90–$15.10. Stryker Trading Down 1.0%Shares of Stryker stock traded down $3.45 during trading on Thursday, hitting $354.39. In other news, CAO William E. Berry, Jr. sold 1,953 shares of Stryker stock in a transaction dated Friday, November 14th. In the last 90 days, insiders have sold 522,118 shares of company stock worth $185,381,932.